QS Investors, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 164 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2021$714,000
-9.5%
8,1120.0%0.01%
-11.1%
Q1 2021$789,000
-12.2%
8,112
+1.2%
0.01%
-18.2%
Q4 2020$899,000
+19.7%
8,012
-1.1%
0.01%
+10.0%
Q3 2020$751,000
-74.3%
8,100
-78.3%
0.01%
-75.6%
Q2 2020$2,918,000
+33.4%
37,4000.0%0.04%
+17.1%
Q1 2020$2,188,000
-30.3%
37,400
-2.1%
0.04%
+12.9%
Q4 2019$3,140,000
+11.1%
38,200
-0.7%
0.03%0.0%
Q3 2019$2,827,000
-22.1%
38,4750.0%0.03%
-20.5%
Q2 2019$3,630,000
+16.0%
38,475
-1.6%
0.04%
+14.7%
Q1 2019$3,130,000
+47.2%
39,092
-0.9%
0.03%
+25.9%
Q4 2018$2,126,000
-30.9%
39,4350.0%0.03%
-10.0%
Q3 2018$3,078,000
+4297.1%
39,435
+3485.0%
0.03%
+2900.0%
Q2 2018$70,000
-30.7%
1,1000.0%0.00%0.0%
Q1 2018$101,000
-41.6%
1,100
-52.2%
0.00%
-50.0%
Q4 2017$173,0002,3000.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders